G vs. MRK
Compare and contrast key facts about Genpact Limited (G) and Merck & Co., Inc. (MRK).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: G or MRK.
Performance
G vs. MRK - Performance Comparison
Returns By Period
In the year-to-date period, G achieves a 31.58% return, which is significantly higher than MRK's -10.38% return. Over the past 10 years, G has outperformed MRK with an annualized return of 10.75%, while MRK has yielded a comparatively lower 8.68% annualized return.
G
31.58%
15.75%
32.53%
35.11%
3.03%
10.75%
MRK
-10.38%
-11.80%
-25.99%
-3.28%
6.70%
8.68%
Fundamentals
| G | MRK | |
|---|---|---|
| Market Cap | $8.23B | $249.37B |
| EPS | $3.64 | $4.78 |
| PE Ratio | 12.82 | 20.62 |
| PEG Ratio | 1.70 | 0.07 |
| Total Revenue (TTM) | $4.66B | $63.22B |
| Gross Profit (TTM) | $1.65B | $48.80B |
| EBITDA (TTM) | $584.78M | $18.85B |
Key characteristics
| G | MRK | |
|---|---|---|
| Sharpe Ratio | 1.36 | -0.17 |
| Sortino Ratio | 2.51 | -0.09 |
| Omega Ratio | 1.31 | 0.99 |
| Calmar Ratio | 0.90 | -0.13 |
| Martin Ratio | 5.19 | -0.36 |
| Ulcer Index | 7.19% | 9.74% |
| Daily Std Dev | 27.50% | 20.69% |
| Max Drawdown | -64.14% | -68.63% |
| Current Drawdown | -12.67% | -27.41% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between G and MRK is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
G vs. MRK - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Genpact Limited (G) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
G vs. MRK - Dividend Comparison
G's dividend yield for the trailing twelve months is around 1.32%, less than MRK's 3.21% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
G Genpact Limited | 1.32% | 1.59% | 1.08% | 0.81% | 0.95% | 0.81% | 1.11% | 0.76% | 0.00% | 0.00% | 0.00% | 0.00% |
MRK Merck & Co., Inc. | 3.21% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.43% | 3.12% | 3.46% |
Drawdowns
G vs. MRK - Drawdown Comparison
The maximum G drawdown since its inception was -64.14%, smaller than the maximum MRK drawdown of -68.63%. Use the drawdown chart below to compare losses from any high point for G and MRK. For additional features, visit the drawdowns tool.
Volatility
G vs. MRK - Volatility Comparison
Genpact Limited (G) has a higher volatility of 11.01% compared to Merck & Co., Inc. (MRK) at 5.26%. This indicates that G's price experiences larger fluctuations and is considered to be riskier than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
G vs. MRK - Financials Comparison
This section allows you to compare key financial metrics between Genpact Limited and Merck & Co., Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities